Remove 2009 Remove Disease Remove Nurses Remove Vaccine
article thumbnail

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

The Pharma Data

2 However, serious disease may occur in individuals with compromised immune systems, which includes patients who received immunosuppressants associated with various types of transplants including hematopoietic stem cell transplants (HSCT) or solid organ transplants (SOT). 2009 Dec; 100(6):479-501. Accessed on December 2, 2020.

article thumbnail

Comment: Drug discovery and the International Day of Action for Women’s Health

Drug Discovery World

Furthermore, insufficient availability and analysis of women-specific health data undermine advancements in disease-state understanding and limit asset discovery opportunities across medical conditions with meaningful unmet need.” 1 Clinical trials Until recently, medicines and vaccines were mainly tested on men.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The New Fungus Among Us, Candida auris

PLOS: DNA Science

. “What is different and particularly scary about Candida auris is that it can survive on skin and healthcare surfaces up to two weeks, allowing the spread from person-to-person in healthcare settings and nursing homes. A vaccine being developed at the Lundquist Institute of UCLA so far works in mice and can be teamed with antifungals.

DNA 52
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Non-alcoholic fatty liver disease and fructose: bad for us, better for mice. Grading scale of visceral adipose tissue thickness and their relation to the nonalcoholic fatty liver disease. 2009 Jun;139(6):1242S-1245S. Fructose as a key player in the development of fatty liver disease. Nonalcoholic fatty liver disease.

Disease 52